Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry

CONCLUSION: When considering the favorable scores on other PROMs and the TSQM v. II, and comparing these to the relatively low percentage of patients perceiving control according to the ADCT, interpretability of eczema control still appears difficult. Treatment satisfaction in the studied cohort was high.PMID:34151695 | DOI:10.1080/09546634.2021.1937485

Source: Journal of Dermatological Treatment - June 21, 2021 Category: Dermatology Authors: Jart A F Oosterhaven Lotte S Spekhorst Junfen Zhang Angelique N Voorberg Geertruida L E Romeijn Celeste M Boesjes Marlies de Graaf Marjolein S de Bruin-Weller Marie L A Schuttelaar Source Type: research